4

OWNERSHIP DOCUMENT

Company: KalVista Pharmaceuticals, Inc.
Filed: September 29, 2017
Period of Report: September 27, 2017
Accession Number: 0001144204-17-050706

View Document ↗ View on SEC.gov ↗